Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

NCT06395220 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06395220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06395220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
June 1, 2025
Enrollment
314 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haematological malignancy